Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

4.730 +2.000 (+73.26%)
Official Closing Price Updated: 4:00 PM EDT, Mar 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 64,635,009
Open 2.780
Bid (Size) 4.470 (600)
Ask (Size) 4.510 (100)
Prev. Close 2.730
Today's Range 2.780 - 5.380
52wk Range 0.6930 - 46.53
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's session ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill

Performance

YTD
+287.7%
+287.7%
1 Month
+408.3%
+408.3%
3 Month
+272.4%
+272.4%
6 Month
-8.5%
-8.5%
1 Year
-45.3%
-45.3%

More News

Read More
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Gapping stocks in Tuesday's session ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Tuesday. ↗
Via Chartmill
News headline image
Why Did BIAF Stock Surge 20% In Pre-Market Today? ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures
From bioAffinity Technologies, Inc.
Via Business Wire
These stocks are moving in today's session ↗
Via Chartmill
Gapping stocks in Monday's session ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
bioAffinity Technologies Stock Cools Off After Strong Friday Rally - Here's Why ↗
Via Benzinga
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
These stocks are making the most noise in today's session. ↗
Via Chartmill
Which stocks have an unusual volume on Friday? ↗
Via Chartmill
Which stocks are experiencing notable movement on Friday? ↗
Via Chartmill
Friday's session: gap up and gap down stocks ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
News headline image
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung
From bioAffinity Technologies, Inc.
Via Business Wire
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic
From bioAffinity Technologies, Inc.
Via Business Wire

Frequently Asked Questions

Is bioAffinity Technologies, Inc. - Common Stock publicly traded?
Yes, bioAffinity Technologies, Inc. - Common Stock is publicly traded.
What exchange does bioAffinity Technologies, Inc. - Common Stock trade on?
bioAffinity Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for bioAffinity Technologies, Inc. - Common Stock?
The ticker symbol for bioAffinity Technologies, Inc. - Common Stock is BIAF on the Nasdaq Stock Market
What is the current price of bioAffinity Technologies, Inc. - Common Stock?
The current price of bioAffinity Technologies, Inc. - Common Stock is 4.730
When was bioAffinity Technologies, Inc. - Common Stock last traded?
The last trade of bioAffinity Technologies, Inc. - Common Stock was at 03/23/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.